| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Langer Dennis is a Director at MYRIAD GENETICS INC with holdings across 3 companies. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $789K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14, 2025 | QNRX Quoin Pharmaceuticals, Ltd. | Director | Buy | 15,152 | $8.49 | $128,640.48 | +1,515,200% | -16.6% | - | |
| Jun 7, 2024 | QNRX Quoin Pharmaceuticals, Ltd. | Director | Sell | 297 | $0.73 | $217.40 | -84.9% | +10.7% | -65.0% | |
| Aug 3, 2021 | MYGN Myriad Genetics Inc | Director | Sale+OE | 30,000 | $34.75 | $1,042,500.00 | -25.1% | -11.5% | -26.4% | |
| Jun 8, 2018 | MYGN Myriad Genetics Inc | Director | Sale+OE | 20,369 | $39.35 | $801,594.13 | -14.6% | - | - | |
| Jun 5, 2018 | MYGN Myriad Genetics Inc | Director | Sale+OE | 49,631 | $39.30 | $1,950,276.90 | -23.8% | - | - | |
| May 30, 2018 | MYGN Myriad Genetics Inc | Director | Sale+OE | 10,000 | $37.92 | $379,245.00 | -20.1% | - | - | |
| May 21, 2018 | MYGN Myriad Genetics Inc | Director | Sale+OE | 10,000 | $35.90 | $359,000.00 | -20.1% | - | - |